Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Amin H Nassar; Talal El Zarif; Ahmed Bilal Khalid; Serena Rahme; Caiwei Zhong; Lucia Kwak; Marita Salame; Elias Bou Farhat; Dory Freeman; Edward El-Am; Arjun Ravishankar; Bachar Ahmad; Frank Aboubakar Nana; David Kaldas; Abdul Rafeh Naqash; Elad Sharon; Nicole R LeBoeuf; Alessio Cortellini; Andrea Malgeri; Shruti Gupta; Ahmad Al-Hader; Jeffrey A Sparks; Jenny Linnoila; Ole-Petter R Hamnvik; Tarek H Mouhieddine; Thomas Marron; Kaushal Parikh; Rana R McKay; Thomas Dilling; Toni K Choueiri; Elio Adib; Elie Najem; So Yeon Kim; Guru Sonpavde

doi:10.1136/jitc-2023-008724

Article info

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Authors

Amin H Nassar Yale University, New Haven, Connecticut, USA PubMed articles Google scholar articles
Talal El Zarif Yale University, New Haven, Connecticut, USAYale University School of Medicine, New Haven, Connecticut, USADepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articles Google scholar articles
Ahmed Bilal Khalid Indiana Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA PubMed articles Google scholar articles
Serena Rahme Department of Cardiovascular Medicine, Mayo Clinic, Rochester, New York, USA PubMed articles Google scholar articles
Caiwei Zhong Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articles Google scholar articles
Lucia Kwak Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articles Google scholar articles
Marita Salame Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Elias Bou Farhat Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articles Google scholar articles
Dory Freeman Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA PubMed articles Google scholar articles
Edward El-Am Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Arjun Ravishankar Yale University, New Haven, Connecticut, USAYale University School of Medicine, New Haven, Connecticut, USA PubMed articles Google scholar articles
Bachar Ahmad Yale University, New Haven, Connecticut, USAYale University School of Medicine, New Haven, Connecticut, USA PubMed articles Google scholar articles
Frank Aboubakar Nana Division of Pneumology, CHU UCL Namur, Yvoir, Namur, BelgiumDivision of Pneumology, Cliniques universitaires Saint-Luc, Brussels, Belgium PubMed articles Google scholar articles
David Kaldas Department of Internal Medicine, University of South Florida, Tampa, Florida, USADepartment of Clinical Oncology, Cairo University, Giza, Egypt PubMed articles Google scholar articles
Abdul Rafeh Naqash Medical Oncology/TSET Phase 1 Program, The University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, USA PubMed articles Google scholar articles
Elad Sharon National Cancer Institute, Bethesda, Maryland, USA PubMed articles Google scholar articles
Nicole R LeBoeuf Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Alessio Cortellini Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, ItalyDepartment of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy PubMed articles Google scholar articles
Andrea Malgeri Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy PubMed articles Google scholar articles
Shruti Gupta Brigham and Women's Hospital, Boston, Massachusetts, USA PubMed articles Google scholar articles
Ahmad Al-Hader Indiana Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA PubMed articles Google scholar articles
Jeffrey A Sparks Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Jenny Linnoila Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articles Google scholar articles
Ole-Petter R Hamnvik Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Tarek H Mouhieddine Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Thomas Marron Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Kaushal Parikh Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Rana R McKay Division of Medical Oncology, University of California San Diego, La Jolla, California, USA PubMed articles Google scholar articles
Thomas Dilling Department of Internal Medicine, University of South Florida, Tampa, Florida, USA PubMed articles Google scholar articles
Toni K Choueiri Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, UK PubMed articles Google scholar articles
Elio Adib Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
Elie Najem Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA PubMed articles Google scholar articles
So Yeon Kim Yale University, New Haven, Connecticut, USA PubMed articles Google scholar articles
Guru Sonpavde Medical Oncology, AdventHealth Central Florida, Orlando, Florida, USAAdventHealth Cancer Institute, AdventHealth, Altamonte Springs, Florida, USA PubMed articles Google scholar articles

Citation

Nassar AH, El Zarif T, Khalid AB, et al

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Journal for ImmunoTherapy of Cancer 2024;12:e008724. doi: 10.1136/jitc-2023-008724

Online issue publication

March 05, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password